Treatment of fulminant hepatic failure. Clinical syndrome and basis of therapy.
作者信息
Williams R
出版信息
Br Med J. 1971 Jan 23;1(5742):213-5. doi: 10.1136/bmj.1.5742.213.
Abstract
摘要
相似文献
1
Treatment of fulminant hepatic failure. Clinical syndrome and basis of therapy.暴发性肝衰竭的治疗。临床综合征及治疗基础。
Br Med J. 1971 Jan 23;1(5742):213-5. doi: 10.1136/bmj.1.5742.213.
2
[Adrenal cortex and mineral metabolism. 2].[肾上腺皮质与矿物质代谢。2]
Med Klin. 1968 Oct 4;63(40):1573-6.
3
MANAGEMENT OF THE HEPATIC COMA SYNDROMES.肝昏迷综合征的管理
Mod Treat. 1964 Mar;1:420-33.
4
[Research on the mechanism of action of various corticosteroid hormones on cellular potassium. II. Relation to glucide metabolism & acid-base equilibrium].[各种皮质类固醇激素对细胞钾作用机制的研究。II. 与糖代谢及酸碱平衡的关系]
Ann Endocrinol (Paris). 1957 Sep-Oct;18(5):681-705.
5
Therapy for cardiogenic shock.
Compr Ther. 1978 Nov;4(11):49-56.
6
Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis.
P R Health Sci J. 1998 Sep;17(3):297-300.
7
[Shock and its treatment wuth chemotherapeutic agents].
Jibiinkoka. 1969 Oct;40(10):843-50.
8
Fulminant viral hepatitis.暴发性病毒性肝炎
Clin Gastroenterol. 1980 Jan;9(1):171-89.
9
BLOOD VOLUME VERSUS CENTRAL VENOUS PRESSURE IN SHOCK.休克时的血容量与中心静脉压
Surg Gynecol Obstet. 1964 Mar;118:594-5.
10
Comprehensive patient management in shock.休克患者的综合管理。
J Am Vet Med Assoc. 1979 Jul 1;175(1):92-6.
引用本文的文献
1
Acute Liver Failure.急性肝衰竭
Clin Liver Dis (Hoboken). 2020 Oct 7;16(Suppl 1):45-55. doi: 10.1002/cld.957. eCollection 2020 Oct.
2
Mannitol treatment of cerebral edema in rats with galactosamine-induced severe hepatitis.甘露醇对氨基半乳糖诱导的大鼠重症肝炎脑水肿的治疗作用
Experientia. 1981 Dec 15;37(12):1323-5. doi: 10.1007/BF01948387.
3
Acute hepatic coma successfully treated by extracorporeal baboon liver perfusions.经体外狒狒肝脏灌注成功治疗急性肝昏迷。
Br Med J. 1972 Jan 1;1(5791):23-5. doi: 10.1136/bmj.1.5791.23.
4
Acute pancreatitis in patients with acute hepatic failure.急性肝衰竭患者的急性胰腺炎
Am J Dig Dis. 1973 Dec;18(12):1079-83. doi: 10.1007/BF01076525.
5
Pancreatitis following liver transplantation.肝移植术后胰腺炎
Transplantation. 1988 Jun;45(6):1062-5. doi: 10.1097/00007890-198806000-00012.
本文引用的文献
1
Effects of chlorpromazine in patients with hepatic disease.氯丙嗪对肝病患者的影响。
Br Med J. 1969 Aug 30;3(5669):497-9. doi: 10.1136/bmj.3.5669.497.
2
Fulminant hepatic failure. Presumable contribution to halothane.暴发性肝衰竭。推测与氟烷有关。
N Engl J Med. 1968 Oct 10;279(15):798-801. doi: 10.1056/NEJM196810102791504.
3
The widening spectrum of neurological damage in liver disease.肝病中神经损伤范围的不断扩大。
Postgrad Med J. 1968 Feb;44(508):173-7. doi: 10.1136/pgmj.44.508.173.
4
Effect of induced metabolic alkalosis in hepatic encephalopathy.
Lancet. 1969 Nov 22;2(7630):1106-8. doi: 10.1016/s0140-6736(69)90706-5.
5
Immune complexes in hepatitis.肝炎中的免疫复合物
Lancet. 1969 Nov 8;2(7628):983-6. doi: 10.1016/s0140-6736(69)90540-6.
6
Cerebral metabolism after portacaval shunt.
Lancet. 1969 Jan 18;1(7586):153. doi: 10.1016/s0140-6736(69)91163-5.
7
Levodopa in hepatic coma.
Lancet. 1970 Dec 26;2(7687):1341-3. doi: 10.1016/s0140-6736(70)92362-7.
Zotero 插件